Jami Rubin's most recent trade in Relay Therapeutics Inc was a trade of 136,681 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Jami Rubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 136,681 | 136,681 | - | - | Stock Option (Right to Buy) | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 196,666 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 51,420 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 0 | - | - | Stock Option | |
| Relay Therapeutics Inc | Jami Rubin | Director | 10 Jun 2024 | 42,242 | 0 | - | - | Stock Option (Right to Buy) | ||
| Relay Therapeutics Inc | Jami Rubin | Director | 10 Jun 2024 | 42,242 | 67,242 | - | 5.0 | 212,900 | Common Stock | |
| Relay Therapeutics Inc | Jami Rubin | Director | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | ||
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Relay Therapeutics Inc | Jami Rubin | Director | 31 May 2023 | 66,055 | 66,055 | - | - | Stock Option (Right to Buy) | ||
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,585 | 302,203 | - | - | Earn-out Shares | |
| Relay Therapeutics Inc | Jami Rubin | Director | 27 May 2022 | 41,597 | 41,597 | - | - | Stock Option (Right to Buy) | ||
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 515,601 | 515,601 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 2,194,500 | 2,194,500 | - | - | Common Stock | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 300,618 | 300,618 | - | - | Earn-out Shares | |
| Relay Therapeutics Inc | Jami Rubin | Director | 20 Jul 2020 | 25,000 | 25,000 | - | 20 | 500,000 | Common Stock |